Title: Comparative Outcomes of ERAS and Conventional Methods in Laparoscopic Sleeve
Gastrectomy: A 5-Year Prospective Cohort Study in Saudi Arabia
Version: 2 Date: 06 Feb 2025
Reviewer:  Antonio Vitiello
Reviewer's report:
This study effectively highlights the benefits of implementing Enhanced Recovery After
Surgery (ERAS) protocols in Laparoscopic Sleeve Gastrectomies (LSG) to address perioperative
complications and prolonged hospital stays. Conducted at the International Medical Centre in
Jeddah, Saudi Arabia, the prospective cohort study involved 94 patients, divided into ERAS
(44) and non-ERAS (50) groups. The results are promising, showing that the ERAS group
had a significantly shorter length of stay (2.05 days vs. 2.20 days, p<0.001), with many
patients discharged the day after surgery. Additionally, healthcare costs were lower, and fewer
postoperative complications were observed in the ERAS group. Remarkably, 100% of ERAS
patients were mobile on postoperative day 0 compared to only 25% in the non-ERAS group,
and a greater percentage began oral intake on the day of surgery. At the five-year follow-up, the
ERAS group continued to show better outcomes, with fewer complications, lower recurrence
of weight gain, and gastroesophageal reflux disease (GERD). Although the study has shown
the efficacy of ERAS in improving LSG outcomes, the small sample size suggests the need for
further research to solidify these findings and explore long-term benefits further. Overall, the
study demonstrates the potential of ERAS to revolutionize perioperative bariatric care practices,
providing compelling evidence for its widespread adoption.
Title: Comparative Outcomes of ERAS and Conventional Methods in Laparoscopic Sleeve
Gastrectomy: A 5-Year Prospective Cohort Study in Saudi Arabia
Version: 2 Date: 06 Feb 2025
Reviewer:  Antonio Vitiello
Reviewer's report:
This study effectively highlights the benefits of implementing Enhanced Recovery After
Surgery (ERAS) protocols in Laparoscopic Sleeve Gastrectomies (LSG) to address perioperative
complications and prolonged hospital stays. Conducted at the International Medical Centre in
Jeddah, Saudi Arabia, the prospective cohort study involved 94 patients, divided into ERAS
(44) and non-ERAS (50) groups. The results are promising, showing that the ERAS group
had a significantly shorter length of stay (2.05 days vs. 2.20 days, p<0.001), with many
patients discharged the day after surgery. Additionally, healthcare costs were lower, and fewer
postoperative complications were observed in the ERAS group. Remarkably, 100% of ERAS
patients were mobile on postoperative day 0 compared to only 25% in the non-ERAS group,
and a greater percentage began oral intake on the day of surgery. At the five-year follow-up, the
ERAS group continued to show better outcomes, with fewer complications, lower recurrence
of weight gain, and gastroesophageal reflux disease (GERD). Although the study has shown
the efficacy of ERAS in improving LSG outcomes, the small sample size suggests the need for
further research to solidify these findings and explore long-term benefits further. Overall, the
study demonstrates the potential of ERAS to revolutionize perioperative bariatric care practices,
providing compelling evidence for its widespread adoption.
Please review this paper.
user
Title: Comparative Outcomes of ERAS and Conventional Methods in Laparoscopic Sleeve
Gastrectomy: A 5-Year Prospective Cohort Study in Saudi Arabia
Version: 2 Date: 06 Feb 2025
Reviewer:  Antonio Vitiello
Reviewer's report:
This study effectively highlights the benefits of implementing Enhanced Recovery After
Surgery (ERAS) protocols in Laparoscopic Sleeve Gastrectomies (LSG) to address perioperative
complications and prolonged hospital stays. Conducted at the International Medical Centre in
Jeddah, Saudi Arabia, the prospective cohort study involved 94 patients, divided into ERAS
(44) and non-ERAS (50) groups. The results are promising, showing that the ERAS group
had a significantly shorter length of stay (2.05 days vs. 2.20 days, p<0.001), with many
patients discharged the day after surgery. Additionally, healthcare costs were lower, and fewer
postoperative complications were observed in the ERAS group. Remarkably, 100% of ERAS
patients were mobile on postoperative day 0 compared to only 25% in the non-ERAS group,
and a greater percentage began oral intake on the day of surgery. At the five-year follow-up, the
ERAS group continued to show better outcomes, with fewer complications, lower recurrence
of weight gain, and gastroesophageal reflux disease (GERD). Although the study has shown
the efficacy of ERAS in improving LSG outcomes, the small sample size suggests the need for
further research to solidify these findings and explore long-term benefits further. Overall, the
study demonstrates the potential of ERAS to revolutionize perioperative bariatric care practices,
providing compelling evidence for its widespread adoption.
assistant